On the recordJune 18, 2018
Now, the President's drug pricing blueprint suggests that the 340B Program, a drug discount program, is causing high drug prices.
Source
congress.govEditor's note · Context
Warren points out the President's claim about the 340B Program's impact on drug prices.
Share
More from Elizabeth Warren
Jul 17, 2026
The gaps in these new disclosure documents reveal the urgent need for this legislation.
Jul 16, 2026
Breaking up the healthcare conglomerates that have enriched themselves by immiserating patients and cheating employers is good policy.
Jul 17, 2026
We need more visibility into what’s happening in these transactions when it has the potential to influence such an important part of our pharmaceutical chain.
Jul 17, 2026
We need independent audits, and we need to rethink these DOD contracts.
Other voices in this conversation
